PetVivo Holdings Inc

PetVivo Holdings Inc operates as a biomedical technology firm specializing in the invention commercialization and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals Its flagship product is Spryng an intraarticular injection administered by veterinarians to effectively alleviate lameness and joint conditions such as osteoarthritis in canines and equines The companys development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications Founded in 2009 PetVivo Holdings Inc maintains its corporate headquarters in Minneapolis Minnesota